Health And Medicine

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. Read More

Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week. Read More

Ellen Wright Clayton, M.D., J.D., the Craig-Weaver Professor of Pediatrics and professor of Law at Vanderbilt University, has won the David Rall Medal from the Institute of Medicine (IOM) for “exemplary” service to the institute. Read More

A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science. Read More

Vanderbilt University Medical Center has joined a national network funded by the National Institutes of Health to streamline multi-site clinical trials focused on key interventions in stroke prevention, treatment and recovery. Read More

Pediatric Infectious Diseases fellow Annabelle de St. Maurice, M.D., has been awarded a grant to determine the relationship between pneumococcal vaccination and the emergence of certain strains of pneumococcal bacteria not covered by vaccines. Read More

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. Read More

A group of Vanderbilt researchers has used laser technology and a custom-built multiphoton microscope to distinguish breast cancer subtypes and determine if specific therapies are working against the cancer cells in as little as two days. Read More

The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. Read More

Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. Read More

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read More

Travis Ladner, a third-year student at the Vanderbilt University School of Medicine, has been selected for a 2013 Congress of Neurological Surgeons (CNS) student fellowship award. The award is presented to a medical student every year from a national pool of applicants. Read More

Vanderbilt University’s Center for Interdisciplinary Health Workforce Studies has been awarded $2.2 million from the Gordon and Betty Moore Foundation to address nursing workforce issues that may impede future health care. Read More

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read More

A recent Vanderbilt study shows a significant number of patients are entering I.C.U.’s throughout the world with no evidence of cognitive — brain related issues, but are leaving with symptoms associated with mild Alzheimer’s or Traumatic Brain Injury. Barb Cramer has more. Read More

As the nation’s health care system undergoes unprecedented challenges, Melinda Buntin’s appointment as chair of Vanderbilt’s new Department of Health Policy couldn’t come at a better time. Read More

When physician Jay Wellons was explaining to his son why the family was moving to Nashville, he put it in terms to which the 7-year-old could relate. “Daddy has a chance to join the Avengers,” he said. Read More

Thomas Wang was born in Boston, raised in Boston and educated in Boston. But Vanderbilt's emphasis on personalized medicine in both research and clinical implementation lured him to Nashville. Read More

When Todd Monroe’s grandmother was diagnosed with breast cancer late in the course of her dementia, the nursing home staff caring for her struggled to assess her pain. Read More

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. Read More